The multi-chambered mammalian heart arises from a simple tube by polar elongation, myocardial differentiation and morphogenesis. Members of the large family of T-box (Tbx) transcription factors have been identified as crucial players that act in distinct subprogrammes during cardiac regionalization. Tbx1 and Tbx18 ensure elongation of the cardiac tube at the anterior and posterior pole, respectively. Tbx1 acts in the pharyngeal mesoderm to maintain proliferation of mesenchymal precursor cells for formation of a myocardialized and septated outflow tract. Tbx18 is expressed in the sinus venosus region and is required for myocardialization of the caval veins and the sinoatrial node. Tbx5 and Tbx20 function in the early heart tube and independently activate the chamber myocardial gene programme, whereas Tbx2 and Tbx3 locally repress this programme to favour valvuloseptal and conduction system development. Here, we summarize that these T-box factors act in different molecular circuits and control target gene expression using diverse molecular strategies including binding to distinct protein interaction partners.
Basic concepts in vertebrate cardiogenesis: continuous elongation and regionalization of a simple tube
The vertebrate heart is a muscular pump that generates an efficient blood flow to support the tissues and organs of the body with oxygen and nutrients. The structural basis of this ability is the progressive reorganization of the initially simple heart tube into one with distinct chambers, the walls of which are triggered to contract sequentially by an elaborate conduction system. Compartmentalization into chambers is achieved by intervening and flanking valves and septa, respectively, that prevent the reflux and separate the flows of blood containing low-and high-oxygen content. Since chamber function is strongly affected by insults to the integrity of the valves, septa, and the various components of the conduction system, which frequently occur in human congenital disease, it is crucial to understand the cellular and molecular programmes that govern the formation of a compartmentalized heart from an initial rudiment. In contrast to any other organ, heart development is under the particular constraint that a functional organ has to be established early in embryonic life, and has to grow and be remodelled while already under a work load in the growing embryo. For a long time, it was thought that the simple tubular heart possesses all the regional identities present in the mature heart, i.e. that chambers arise by differential expansion of prespecified segments. Both molecular analyses and lineage tracing experiments have challenged this concept in recent years and suggested that different pools of precursor cells differentially contribute to the growing heart, and that chambers arise locally and sequentially in an initially homogenous cardiac tube. 1, 2 In the mouse, bilateral subregions of the anterior lateral plate mesoderm [the so-called first heart field (FHF)] are specified to a cardiac fate and fuse at the midline to form a crescent-like structure from which a simple tube forms around embryonic day (E) 8.0 (see Figure 1 for morphological stages of murine heart development, and the contribution of different precursor pools to the forming chambers). The myocardium present within this tube features a low proliferation rate, low conduction velocity, and the ability to depolarize spontaneously; it allows the generation of peristaltic contractions to pump the blood directionally from a posterior inflow to an anterior outflow region. The tube is further elongated until E9.5 by recruitment and delayed myocardial differentiation of precursor cells from the pharyngeal mesoderm [the second heart field (SHF)] at the two poles. In fact, cells from the FHF are known to contribute only to the left ventricle and the atrioventricular canal (AVC), whereas the atria, the right ventricle and the outflow tract (OFT) largely derive from mesenchymal precursors residing in the SHF. Concomitant with the morphogenetic process of looping that repositions the venous pole anteriorly, chambers start to become evident in discrete zones within the outer curvature of the growing heart tube at E8.5 -9.0; ventricles first on the ventral, and slightly later, atria on the dorsal -lateral aspect. Owing to an increased proliferation rate, these chambers enlarge in a balloon-like fashion. Chamber myocardium features a high contractility and fast conduction rate that enable this tissue to endure continuous mechanical work. In contrast, the regions flanking and separating the chamber myocardium, the inflow tract (IFT), OFT, and the AVC, retain their less differentiated myocardial phenotype, and display a lower proliferation rate and poor electrical coupling. This results in the generation of primitive anatomical constrictions that prevent reflux and decelerate the transfer of electrical excitation coming from the posterior heart pole. The primary myocardium in the AVC and OFT contributes to the conduction system, plus induces cells derived from the overlying endothelium to delaminate and populate the extracellular matrix of the cardiac jelly as mesenchymal cells, and form cushions from which valves will subsequently develop.
1,2 Thus, formation of a compartmentalized heart relies on the ordered deployment of myocardial progenitor pools and the establishment of a myocardial dichotomy in the growing cardiac tube.
T-box genes: an ancient family of developmental regulators
Given the spatiotemporal complexity of cellular differentiation pathways in the developing heart, it seems mandatory that a large number of intercellular signalling modules and intracellular transcriptional circuits act together to achieve cardiac regionalization. Although the complexity of the molecular players and their interactions are not yet completely understood, a wealth of information suggests that members of the T-box gene family are particularly important regulators of myocardial proliferation and patterning. T-box genes encode transcription factors that are characterized by a highly conserved DNA-binding region. This T-box recognizes a specific DNA element, the T-half site, that occurs singly, or in multiples with different orientation and spacing in promoters of target genes, and mediates transcriptional activation and/or repression. 3 The T-box, however, is not only a conserved DNA-binding region, but also a conserved interaction domain for other transcription factors, chromatin remodelling complexes and histone-modifying enzymes involved in transcriptional control. 4 With the completion of whole genome sequencing efforts, we now have a better picture of the presence of T-box gene families of various sizes in most animal species. In mouse and man 17 Tbx genes organized in five subfamilies are present and are specifically expressed within progenitor fields, including those of the early germ layers, and in organ rudiments of the developing embryo. T-box genes often act in a combinatorial or hierarchical fashion and frequently exhibit an exquisite dose-sensitivity in controlling a diverse set of developmental processes, most prominently differentiation and patterning. It may be for this reason that haplo-insufficiency of a large proportion of these genes is associated with human congenital diseases, and that overexpression of some family members has been linked to cancer. 5 In the developing mammalian heart, 6 of the 17 family members (Tbx1, Tbx18 and Tbx20 of the Tbx1 subfamily, and Tbx2, Tbx3 and Tbx5 of the Tbx2 subfamily) are expressed and required in a combinatorial fashion in different progenitor pools as well as in different compartments ( Figure 2) . 6, 7 Cardiac T-box gene expression is not restricted to mammals but is conserved throughout the vertebrate lineage. Evolutionary conservation even extends to the development of the uncompartmentalized heart tube of invertebrates such as in Drosophila. 8 Here, we will review the role of T-box genes in cardiac regionalization and relate it to their molecular function as transcription factors acting in complex regulatory networks (for a summary see Table 1 ). Owing to space constraints we will restrict ourselves to the situation in the mammalian heart that has been most vigorously studied.
3. Keeping the tube growing: Tbx1 in control of SHF proliferation Around E8.25 cells from the FHF have established a tubular working heart. This tube subsequently elongates by addition of precursor cells from the pharyngeal mesoderm, the SHF. Cells from the FHF and SHF are contiguous in the embryo, and are distinguished by immediate and delayed myocardial differentiation, respectively. Consequently, T-box genes in cardiac development SHF cells need to be maintained in a proliferative state until they receive a local signal to differentiate. Not surprisingly from our present perspective, the balance between proliferation and differentiation is tightly controlled in space and time by a network of signalling pathways and downstream transcription factors in which the T-box factor, Tbx1, plays a particularly prominent role ( Figure 3 ). 9 Tbx1 is expressed in the mesoderm and endoderm of the pharyngeal arches, and in the OFT in mice. Genetic lineage analysis have demonstrated that Tbx1-positive cells of the pharyngeal mesoderm contribute extensively to the OFT myocardium, endocardium, and mesenchymal cushions between E8.5 and E9.5 suggesting that Tbx1 acts in an anterior subdomain of the SHF. 10, 11 Pharyngeal expression of Tbx1 is maintained by sonic hedgehog (Shh). 12 Shh is produced in the pharyngeal endoderm, and in the adjacent mesoderm induces the expression of forkhead class transcription factors FoxA2, FoxC1, and FoxC2 that directly act on the Tbx1 promoter. FoxA2, in turn, is a target of Tbx1, generating a positive feedback loop. 13, 14 Tbx1 expression in the OFT myocardium is under negative control of bone morphogenetic protein (BMP)-regulated microRNAs (miRNAs). Bmp2 and Bmp4 induce the expression of miRNAs of the 17-92 cluster, which directly repress Tbx1 transcripts allowing myocardial differentiation to occur. 15 Mice heterozygous for a null mutation of Tbx1 have mild anomalies, whereas homozygous Tbx1 animals die at birth with severe defects in the derivatives of the pharyngeal apparatus. Cardiac defects include persistent truncus arteriosus, ventricular septal defects (VSDs), and mispatterning of the coronaries. Conditional deletion of Tbx1 from the pharyngeal endoderm and mesoderm, respectively, results in a spectrum of cardiovascular defects resembling those of the null mutants. However, mesodermal re-expression of Tbx1 in a null background corrected most of these defects, suggesting cross-talk between the two tissues. 16 Tbx1 function in the pharyngeal mesoderm is additionally required non-cell autonomously for survival, differentiation, and migration of the neural crest, a function that may be partly mediated by the homeobox transcription factor Gbx2. 17 Loss of TBX1 has been identified as a major factor contributing to the phenotypic changes observed in DiGeorge or 22q11 deletion syndrome, the most common human deletion syndrome. 18 Cardiovascular defects of Tbx1-deficient mice were traced to a severe reduction in proliferation in the anterior SHF. Tbx1 null mice show reduced expression of fibroblast growth factors (Fgf)8 and 10 in the pharyngeal mesoderm while overexpression of Tbx1 in the OFT induces expression of these genes. These and genetic interaction studies suggest that Fgf8 and Fgf10 act downstream of Tbx1 in maintaining proliferation of the SHF. This regulation seems direct since Tbx1 binds to conserved T-half sites in the promoters of these genes. Tbx1 is also involved in asymmetric cardiac morphogenesis via the synergistic activation of the bicoid-like homeodomain transcription factor Pitx2 together with the cardiac transcription factor Nkx2-5 in the left pharyngeal mesenchyme. 16 However, Tbx1 is likely to regulate a greater set of genes than just Fgf8, Fgf10, and Pitx2. Indeed, microarray analysis detected .200 significantly up-and down-regulated genes in the pharyngeal region of Tbx1-deficient mice. 19 Interestingly, expression of the gene encoding the retinoic acid (RA)-synthesizing enzyme Aldh1a2 was up-regulated, whereas Cyp26a1,b1,c1 that metabolize RA were down-regulated in this microarray. Blockade of Cyp26 function in the chick embryo using a specific inhibitor resulted in a dose-dependent phenocopy of Tbx1-null cardiovascular defects, collectively suggesting that increased RA signalling contributes to the Tbx1 loss-of-function phenotype. 20 How does Tbx1 activate target gene transcription? Stoller et al. used a yeast-2-hybrid assay to search for functionally relevant Tbx1-interacting proteins. They identified and confirmed physical and functional interaction between Tbx1 and Ash2l. Ash2l is the mammalian homologue of Drosophila Ash2 (absent small homeotic 2) and is a core component of a multimeric histone methyltransferase complex that epigenetically regulates transcription via trimethylation of lysine residue 4 in histone H3. 21 Thus, transcriptional activation by Tbx1 may be at least partly mediated by direct interactions with a histone methyltransferase complex. However, Tbx1 may not only rely on its DNA-binding ability to control target gene transcription as it interacts with phosphorylated Smad1 in a DNA-independent fashion. This interferes with P-Smad1/Smad4 complex formation, and Bmp target gene activation and may aid in maintaining the SHF precursor pool and consequently the anterior elongation of the cardiac tube. 22 
Adding it on late: Tbx18 at the sinus venosus region
The venous pole of the developing heart is particularly complex area since it contributes to the outer tissue layer of the heart, the cardiac Figure 2 Combinatorial expression of T-box genes in murine heart development. Schemes of T-box gene expression in E8.5, E10.5, and E14.5
hearts. The E8.5 heart is depicted in a lateral and frontal view. The E10.5 and E14.5 hearts represent schematic transverse sections through the heart. For abbreviations see Figure 1 . *1 van gogh; *2 org-1; *3 omb; *4 heartstring; *5 Hrt; *6 nrm1 (H15), nrm2 (midline). Species: m, mouse; h, human; ch, chick; X, Xenopus laevis; z, zebrafish; Dm, Drosophila melanogaster. ASD, atrial septal defect; aSHF, anterior second heart field; AV, atrioventricular; CHD, congenital heart defect; OFT, outflow tract; SAN, sinoatrial node; VSD, ventricular septal defect.
pacemaker, as well to the myocardium of the sinus venosus region. From E9.0 on, cells of the proepicardium (PE), a mesothelial cell cluster in the centre of the septum transversum region, float through the pericardial space, adhere to the myocardium, and spread out over its surface to form a continuous epithelial layer around E11.0. A subset of these epicardial cells undergoes an epithelial-to-mesenchymal transition, migrates into the subepicardial space, and invades the underlying myocardium. Cell lineage tracings mainly done in the chick showed that subepicardial mesenchyme further differentiates into interstitial and perivascular fibroblasts, in smooth muscle and coronary endothelial cells. 23, 24 Genetic fate mapping studies in the mouse suggested that a substantial fraction of cardiomyocytes may also be derived from epicardial cells. 25, 26 The sinus venosus represents the unpaired collecting chamber of the cardinal veins that lies posterior to the common atrium. Until E9.5, it features a mesenchymal wall that may be considered as a lateral extension of the proepicardial serosa. This wall gradually myocardializes and is taken up into the forming atria. From E9.5 to E14.5, the sinus venosus mesenchyme provides the sinus horns as well as the myocardium of the large head region of the sinoatrial node (SAN) that is embedded in the sinus horn myocardium.
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Tbx18 is a member of the Tbx1 subfamily that is associated with the cardiac venous pole. Expression is found in the PE, in the epicardium, and both in mesenchymal progenitors as well as in differentiated myocardium of the sinus venosus region. 28 Expression of
Tbx18 is adjacent but distinct from the Nkx2-5 and Isl1 expression domains that mark the precursor cells of the atria and ventricles, the FHF and SHF. 27 Correspondingly, genetic lineage analysis
showed that the Tbx18-descendants form the sinus horn and the SAN myocardium, but do not contribute to the atrial and pulmonary vein myocardium that instead are descendents of SHF progenitors. 29 An independent study suggested that Tbx18-positive epicardial cells contribute to another pool of cardiomyocytes of the interventricular septum and the left ventricle. 25 However, endogenous expression of Tbx18 in exactly these regions from as early as E10.5 questions the suitability of the Tbx18 locus to trace an epicardial origin of these cardiomyocytes. 30 In fact, an alternative
Tbx18-based genetic lineage analysis has provided compelling evidence that epicardial cells only give rise to fibroblasts and smooth muscle lineages in the heart. 31 In any case, it is clear that Tbx18 expression at the posterior pole marks a distinct set of myocardial precursor cells that may be termed a 'third heart field' or a posterior extension of the SHF. Mice homozygous for a Tbx18 null allele are born but exhibit specific defects of the systemic venous return. Caval veins are thinner and take an abnormal lateral position in the pleuropericardial membrane; their myocardial differentiation is severely delayed. The SAN is dramatically reduced, and the border between SAN and atrial myocardium is fuzzy. 27, 32 In contrast, a phenotypic requirement during development of the epicardium and the left ventricular myocardium in which Tbx18 is also expressed, has not yet been presented. Together, these findings argue for a unique function of Tbx18 in proliferation, differentiation, and selective recruitment of precursor cells of a distinct posterior pool during formation of the systemic venous return.
To date, the molecular circuits, that act downstream of Tbx18 in the formation of the systemic venous return and the epicardium, are unknown. However, in vitro and overexpression experiments suggest that Tbx18 encodes a repressor of gene transcription. 33, 34 Repression partly depends on the presence of an eh1-motif in the Nterminus of the protein. 33 This motif represents a binding site for groucho proteins that are members of a family of transcriptional corepressor. Groucho proteins are known to recruit histone deacetylases that remove acetyl groups from histone tails, thus, rendering the chromatin inaccessible for transcriptional activation.
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Tbx18 homodimerizes and heterodimerizes with other T-box proteins, as well as with a number of cardiac and non-cardiac transcription factors, including Nkx2-5 and Gata4. 33 These interactions may not occur in vivo due to the lack of coexpression, but they testify to the potential of Tbx18 to interact with a large set of DNA-binding domains of other transcription factor families and thus increase target site specificity. F. Greulich et al.
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. Driving the chamber myocardial gene programme into the posterior heart tube: Tbx5 in activating action
After establishment of a simple cardiac tube in late gastrulation stage embryos, further elongation at the poles is accompanied by a myocardial patterning process that drives the formation of localized chambers with a distinct gene signature including expression of Nppa, Chisel, and Cx40. Tbx5 and Tbx20 are two distantly related T-box genes that play crucial roles in this programme. Tbx5 transcripts are first found in the bilateral wings of the cardiogenic mesoderm and later in the endocardium and myocardium of the inflow region, the atria, the AVC and the left ventricle, but not in the right ventricle and OFT of the linear, looping and chambered-heart, strongly suggesting that expression is mainly associated with the FHF and its derivatives. 36 The factors that control cardiac Tbx5 expression have remained poorly defined. RA signalling has been implicated in restricting Tbx5 expression to the posterior part of heart tube, and JAK-STAT3 signalling is sufficient and required to activate the expression of Tbx5 in P19CL6 cells.
37,38
Both gain-and loss-of-function experiments have addressed the functional significance of regionalized expression of Tbx5 in the developing heart. Heart-wide overexpression of the gene in mice resulted in looping defects, expansion of left ventricular identity and loss of the ventricular septum and AV cushions. 39 Mosaic expression of Tbx5 in chick embryos led to formation of additional ventricular septa, collectively arguing that Tbx5 confers left ventricular or posterior identity to the heart tube. 39 Mice homozygous for a Tbx5 null mutation establish a linear heart tube, but components derived from the FHF become hypoplastic. 40 In humans several different mutations in the TBX5 gene are associated with Holt -Oram Syndrome (HOS), a disease entity associated with severe limb and heart abnormalities including septal defects as well as conduction disease. 41, 42 Heterozygous Tbx5 mutant mice remarkably resemble the HOS phenotype confirming the dose-sensitive role of Tbx5 to induce and maintain posterior chamber identity. 40 Biochemical analyses suggest that Tbx5 acts as a transcriptional activator that associates with different co-factors to achieve differential activation of chamber myocardial genes ( Figure 4) . Analysis of the murine Nppa promoter revealed two T-half sites that are bound by Tbx5 and a site for the NK-type homeobox transcription factor Nkx2-5 in close proximity. Nkx2-5 is an evolutionary conserved cardiac transcription factor that is expressed in the FHF and SHF and is also required for chamber formation. 40, 43, 44 Cooperative DNA binding and Nppa transactivation by Tbx5 and Nkx2-5 is aided by complex formation between the two proteins and a third transcription factor, the zinc-finger protein Gata4. 43, 45 A possible molecular mechanism of Gata4 function in this complex was recently proposed by Takeuchi and Bruneau. 46 These researchers identified Gata4 and Baf60c, the cardiac-specific component of the Swi/ Snf-like BAF chromatin remodelling complex, to be essential and sufficient to drive mouse mesoderm into a cardiac lineage, and Tbx5 as sufficient for terminal differentiation into beating cardiomyocytes.
Interesting for future therapeutic avenues may be the finding that Tbx5 in combination with myocyte-specific enhancer factor 2c (Mef2c) and Gata4 is able to reprogramme fibroblasts into functional cardiomyocytes in vitro. 47 Interaction of Gata4 with Baf60c exposes Figure 4 Protein interactions in regulation of Tbx5 transcriptional activity. Scheme depicting regulation of (1) Tbx5 transcription by Stat3 signalling and unknown upstream factors, (2) Tbx5 subcellular localization by Crm1-mediated nuclear export and cytoplasmic retention by Pdlim7, and Tbx5 transcriptional activity by association with (3) chromatin remodelling complexes (Baf60c) and (4 and 5) histone-modifying enzymes (TAZ-p300/CAF and Tip60). ? denotes unknown activators or pathways.
T-box genes in cardiac development
Gata4-binding sites in target genes after BAF-mediated chromatin remodelling. A positive effect of Baf60c on the activation of the Nppa promoter in vitro indicates that the interaction of Tbx5 with Gata4 may similarly induce the recruitment of the BAF chromatin remodelling complex to Tbx5 target genes. A direct interaction of Tbx5 and Baf60c in the recruitment of Brgl1 (BAF complex ATPase) was detected in cells over-expressing both factors. 48 Whether this interaction is necessary for the activation of chamberspecific genes in vivo remains to be determined. Tip60, an acetyltransferase for histone and non-histone proteins, was shown to interact with Tbx5 in the activation of serum response factor (Srf), a gene involved in the expression of cardiac, skeletal, and smooth muscle genes. 49 However, the precise mechanism of Tip60-mediated activation is unknown and seems to be specific for Srf since the Nppa promoter was not positively regulated by Tbx5 and Tip60. 50 Interaction of Tbx5 with the transcriptional coactivator TAZ (transcriptional coactivator with PDZ-binding motif) on the other hand was shown to link Tbx5 to the histone acetyltransferases p300 and PCAF (P300/CBP-associated factor) promoting transcriptional activation of Nppa by histone acetylation and increased transcriptional accessibility of the promoter. 50 The differential recruitment of transcriptional co-factors is one mechanism that controls Tbx5 transcriptional activity in time and space. Another possibility is the regulation of the subcellular localization. Tbx5 contains two nuclear localization sequences and one nuclear export signal. 51 The latter mediates Crm1 (chromosome region maintenance 1 protein homologue 1)-dependent nuclear export of Tbx5. 52 Cytoplasmic Tbx5 interacts with the PDZ and LIM domain protein 7 (Pdlim7, also known as LMP4) which itself is bound to the actin cytoskeleton, providing a rapid mechanism of cytoplasmic retention, thus inactivation, of Tbx5. 53 Protein interactions do not only mediate Tbx5 transcriptional activity, they also have a say in defining the transcriptional specificity of this transcription factor. One example is the well-studied synergistic interaction of Tbx5, Nkx2-5, and Gata4 that we described above. Less-understood interactions involve the transcription factors Mef2c and Sall4. During early heart development Mef2c interacts via its MADS-box with the T-box domain of Tbx5 and synergistically activates Myh6 (myosin heavy chain 6). Myh6, that is essential for cardiac muscle contraction, is specifically expressed in the posterior aspects of the linear heart tube. Interestingly, the activation of the Myh6 promoter is dependent on the T-box but independent of the Mef2-binding site. 54 Later in heart development, when the function of Tbx5 changes from chamber differentiation to chamber septation and conduction system development, the transcription factor network involved in the synergistic activation of Tbx5 target genes changes as well. Tbx5 interaction with the zinc-finger transcription factor Sall4 during ventricular septation may serve as an example for such a switch. Sall4 is expressed in the myocardium of the interventricular septum and left ventricle and inhibits the synergistic activation of the Nppa promoter by Tbx5, Nkx2-5, and Gata4. In contrast, Tbx5 and Sall4 synergistically activate the Cx40 promoter. Mice heterozygous for Sall4 as well as mice compound mutant for Sall4 and Tbx5 exhibit severe VSDs and right-ventricular expansion of Nppa expression clearly supporting a role of the Tbx5-Sall4-Nppa feedback loop in ventricular septation. 55 Together, these findings suggest that Tbx5 activates a large set of chamber myocardial genes by differential recruitment of transcription factors and cofactors including chromatin-modifying enzymes and chromatin remodelling complexes. However, Tbx5 has additional functions outside the chamber myocardium in the endocardium, the epicardium, the SAN and the ventricular conduction system that may relate to different molecular circuits. 7 6. Another driver for chamber formation: Tbx20 has a broader mission Bmp signalling is essential for cardiac specification in the FHF but needs to be down-regulated to allow formation of chamber myocardium and the recruitment of SHF progenitors. 56, 57 Tbx20 is a member of the Tbx1 subfamily of T-box transcription factors that is expressed in the FHF and SHF throughout cardiac development. 58, 59 In chick mesendodermal explants Bmp2 induces Tbx20 and other cardiac transcription factors including Nkx2-5 but not Tbx5. 60 The Xenopus Tbx20
promoter contains non-canonical high-affinity-binding sites for Smad transcription factors, the intracellular mediators of Bmp signalling. These sites are both necessary and sufficient to drive cardiac expression in Xenopus, in zebrafish and mouse, strongly arguing that low levels of Bmp signalling induce Tbx20 in the cardiac mesoderm.
61
Neuregulin 1 (Nrg1), a member of the epidermal growth factor family of signalling ligands, is expressed in the endocardium and signals via its receptors ErbB2 and ErbB4 to induce trabeculation in the chamber myocardium. Nrg1 significantly represses Tbx20 expression in a dose-dependent manner in myocardium of cardiac explant cultures, providing a possible mechanism for down-regulation of Tbx20 in myocardium at later stages of heart development. 62 A further hint about Tbx20 upstream regulatory factors came from patients with Tetralogy of Fallot (TOF). Up-regulation of Tbx20 expression in some patients correlated with decreased expression of the transcription factor AP-2gamma (Tcfap2c). Tcfap2c is able to bind and repress the Tbx20 promoter in vitro. 63 As in the case of Nrg, the in vivo significance of Tcfap2c in Tbx20 regulation has remained undefined. Genetic data from mouse and man indicate a crucial and dosesensitive role of Tbx20 for cardiogenesis. Patients with inactivating mutations in the T-box of Tbx20 suffer from diverse cardiac defects including VSD, aberrant valvulogenesis, TOF, and cardiomyopathy. 64, 65 Tbx20-heterozygous mice show onset of a dilated cardiomyopathy, phenocopying at least a subset of the human defects. 62 Although mice with a complete loss of Tbx20 establish a linear heart tube, looping and chamber formation do not occur, proving the absolute requirement of this gene for chamber formation in FHF-derived cells. 62, 66, 67 Graded hypoplasia especially of the right ventricle and OFT was observed in a series of Tbx20 knock-down mouse embryos suggesting that Tbx20 is additionally involved in the development of the SHF. 68 A molecular explanation for the latter is provided by the finding that Tbx20 activates both the Mef2c anterior heart field and the Nkx2-5 cardiac enhancer. 68 Cai et al. 67 observed that Isl1 is up-regulated throughout the heart of Tbx20 mutants and subsequently demonstrated by ChIP analysis and transfection studies that Tbx20 directly binds and represses conserved T-half sites within the Isl1 promoter sequence, suggesting that deregulation of Isl1 also contributes to the SHF phenotype. Similar to the situation in Tbx5-deficient mice, chamber myocardial genes are not activated in Tbx20-mutant hearts. However, in contrast to Tbx5-deficient hearts Tbx20-mutant mice ectopically express Tbx2 throughout the cardiac crescent and the linear heart tube. 62, 66, 67 Tbx2 expression is normally restricted to the AVC and OFT and is involved in inhibition of Tbx5-induced chamber differentiation as well as in endocardial cushion formation. 69, 70 ChIP of embryonic heart extracts and luciferase assays suggested a direct mode of Tbx2 repression by Tbx20. 67 However, a study performed by Singh et al. 71 rejected this possibility, and uncovered an unexpected mode of target gene repression by Tbx20 that is independent of its DNA-binding activity. Similar to Tbx1, Tbx20 binds to activated phospho-Smad1/5 proteins and sequesters them from forming functional heterotrimeric complexes with Smad4. As a consequence, activation of Bmp target genes (including Tbx2) is attenuated, if not abrogated, by Tbx20 in the linear heart tube and forming chambers. Nonetheless, mice double mutant for Tbx20 and Tbx2 still fail to form chambers and to activate the chamber myocardial gene programme, implying additional (activating) functions of Tbx20 in progression from a linear to a looping and chamber-bearing heart. 71 Although Tbx20 binds to Nkx2-5 and Gata4 and synergistically activates the Nppa promoter in vitro, 72, 73 the endogenous targets of Tbx20 in the chamber programme have remained largely enigmatic. It is unknown whether Tbx20 regulates a set of chamber myocardial genes which are different, overlapping or identical with those regulated by Tbx5. The latter seems unlikely given the strong independent requirements of the two genes in chamber formation. Early cardiac arrest in Tbx20-deficient embryos hampered the analysis of Tbx20 gene function at later stages of cardiogenesis. However, loss-and gain-of-function analysis in endocardial cell cultures support a role for Tbx20 in repressing extracellular matrix remodelling and promoting cell proliferation in mesenchymal valve precursor populations during endocardial cushion development. 74 
Setting the borders: Tbx2 and Tbx3 in repressing mission
In the transition from a linear tube to a compartmentalized heart, chambers arise locally, leaving the intervening and flanking regions to form primitive constrictions and valves, and the components of the conduction system. The genes that promote the chamber myocardial gene programme, including Tbx5 and Tbx20, Nkx2-5 and Gata4, however, are not expressed in a localized manner but are activated early and broadly in the precardiac mesoderm. This leaves the possibility that the chamber myocardial gene programme is locally inhibited rather than activated. Tbx2 and Tbx3 are two closely related T-box transcription factor genes, the expression of which is exclusively associated with non-chamber myocardium of the AVC (Tbx2 and Tbx3) and OFT (Tbx2) during cardiac development, suggesting a functional role in setting up this early myocardial dichotomy. 72 Tbx3 is additionally found in epithelia and neural crest cells in the pharyngeal region, in the SAN primordium, and in all mature components of the central conduction system. 73, 75 Given the biochemical similarity and the overlapping expression domains, both genes are likely to act redundantly in the AVC, and show unique requirements in the other expression domains. To date, double mutant mice (Tbx2 2/2 ;Tbx3 2/2 ) have not been reported but mice single mutant for either gene show phenotypes compatible with a role of the two genes in inhibiting the chamber and/or promoting a primitive myocardial programme. Tbx2-deficient mice exhibit septation defects in the OFT and a partial expansion of chamber-specific gene expression into the AVC. 76 Tbx3-deficient mice on the other hand have a normal AVC but OFT development is disturbed. This is probably secondary to an impaired contribution of neural crest cells to the arterial pole of the heart. 75, 77 Development of the ventricular septum is affected similar to some human patients with heterozygous loss of TBX3 in Ulnar-mammary syndrome. 78, 79 The SAN is formed normally but features an atrial instead of an SAN type myocardium. 80 The AV conduction system develops aberrantly. 81 Gain-of-function experiments have provided strong evidence that both Tbx2 and Tbx3 are not only required, but also sufficient to prevent the chamber-myocardial gene programme. In embryos with ectopic expression of Tbx2 or Tbx3, the myocardium remains primitive and the linear heart tube fails to loop and form chambers. 72, 82 Overexpression of Tbx2 in atrial and ventricular myocardium results in ectopic formation of cardiac jelly and cushion tissue again compatible with the induction of a primitive AVC type at the expense of chamber type myocardium. 70 Finally, overexpression of Tbx3 in atrial myocardium results in formation of ectopic pacemakers suggesting that atrial myocardium is respecified towards a nodal type. 80 Habets et al. 69 provided a molecular rationale for these findings based on their biochemical analysis of the Nppa promoter. They showed that Tbx2 similar to Tbx5 (and Tbx20) binds to Nkx2-5 and Gata4 as well as to conserved T-half sites in the Nppa promoter, and effectively inhibits Tbx5-mediated transactivation. Since Tbx2 and Tbx3 can repress target genes, 83 and can interact in vitro and in cancer cell lines with a large number of histone deacetylases, 84 Tbx2 and Tbx3 may not merely behave as competitors that occupy binding sites of the strong activator Tbx5 (and Tbx20) but effectively repress transcription of chamber genes by histone modification. Competition for DNA-binding sites in the promoter of the N-myc1 gene that encodes a pro-proliferative transcription factor may follow a similar theme and may contribute to the decreased proliferation of the non-chamber myocardium. 67 In mice overexpressing Tbx2 late in chamber myocardium, deposition of cardiac jelly and formation of cushion tissue occurred ectopically in the ventricular region and was associated with up-regulation of the marker genes hyaluronan synthase 2 (Has2), and transforming growth factor beta 2 (Tgfb2). The upstream regulatory region of these genes contains two weak T-half sites each and mediates transcriptional activation by Tbx2 in cells. 70 Although more vigorous genetic tests are required to verify these surprising findings, it is tempting to speculate that Tbx2 and Tbx3 repress chamber myocardial genes and activate a different set of target genes specific for AVC myocardium. Such a molecular switch between repressor and activator function is not easy to conceptualize but could be triggered by specific protein interaction partners. While activating co-factors for Tbx2 and Tbx3 have not yet been identified, repressive co-factors like the muscle segment homeobox proteins Msx1 and Msx2 bind to Tbx2 and Tbx3 and suppress Cx43 promoter activity in a rat heartderived cell line. 85 Since chamber myocardial patterning appears to be achieved by localized expression of the transcriptional repressors Tbx2 and Tbx3, the cellular and molecular mechanisms that activate and restrict these factors in the linear and looping heart become of great relevance. To date, the molecular control of cardiac Tbx3 regulation has remained enigmatic, whereas a number of signalling inputs and transcriptional activities have been described to converge on the Tbx2 promoter. The Notch target genes Hey1 or Hey2 are normally expressed in the atrium and ventricle, respectively. Their forced expression in the entire cardiac lineage of the mouse results in the reduction of the AVC, suggesting that transcriptional repression of the Tbx2 promoter by Hey proteins may mediate boundary formation of the AVC in the developing heart. 86, 87 Conditional ablation of Bmp2 from the AVC results in AVC reduction and loss of Tbx2 expression, whereas ectopic Bmp2 was found to induce Tbx2 (and Tbx3) in other experiments. 88, 89 Deletion analysis of the Tbx2 upstream region identified a short genomic fragment that is sufficient to recapitulate cardiac Tbx2 expression in vivo. 70, 71 This regulatory region is responsive to Bmp signalling and contains a large number of weakly conserved binding sites for activating Smad proteins, suggesting that high levels of Bmp/Smad signalling directly activate Tbx2 expression in the AVC and OFT. Precocious activation of Tbx2 by Bmp signalling in the cardiac crescent is inhibited by Tbx20 as described above. 71 In summary, myocardial patterning in the forming cardiac chambers relies on a network of T-box transcription factors that broadly activate or locally inhibit specific myocardial gene programmes. T-box gene function is tightly linked to Bmp signalling, both as targets as well as regulators of this signalling pathway ( Figure 5 ).
Summary and conclusion
Here, we have reviewed experimental findings that a conserved set of T-box genes plays crucial roles in myocardial proliferation and patterning. Tbx5 and Tbx20 are required to initiate and maintain the chamber myocardial gene programme, while Tbx2 and Tbx3 inhibit this programme locally to allow cushion formation and specification of conduction system components between the ballooning chambers. Tbx1 maintains the mesenchymal precursor pool in the pharyngeal mesoderm, and Tbx18 mediates the recruitment and differentiation of mesenchymal progenitors at the cardiac venous pole. While both Tbx5 and Tbx20 act in the evolutionary old programme of the formation of a simple peristaltically active tube, Tbx2/Tbx3 and Tbx1/ Tbx18 functions are clearly related to vertebrate-specific inventions of compartmentalization and further elongation of the linear heart tube. 8 Molecular analyses suggest that Tbx1, Tbx5, and Tbx20 act as transcriptional activators of chamber myocardial genes, whereas Tbx2, Tbx3, and Tbx18 are biased towards repression of possibly a similar set of targets. T-box proteins achieve specificity in their transcriptional properties by spatiotemporally regulated expression and protein interaction. The latter accounts for the recruitment of other transcription factors, as well as transcriptional cofactors that define target site specificity and transcriptional activity.
Although we have learned a lot about individual early function of T-box genes in cardiogenesis, we know much less about their later roles in cardiac development. We also lack insight into their combined and redundant functions in diverse cardiac subprogrammes. Phenotypic analyses of conditional mutant mice and analysis of double mutants should help to clarify these roles during the next few years. While molecular determinants of cardiac expression for Tbx20, Tbx2 and Tbx1 have surfaced, we have no concepts about the upstream pathways initiating and restricting expression of Tbx5, Tbx3, and Tbx18 in the heart. Last, but most importantly, the identity of the full set of transcriptional targets has not been characterized and validated in a single case for cardiac T-box factors. Clearly, the difficulty to get a sufficiently large number of cells expressing a particular T-box gene in a given sub-programme is a major hurdle in this enterprise. However, with the advent of high-throughput sequencing techniques and possibilities to better enrich DNA-binding sites and interaction partners we will get closer towards this goal. In the end, we will not only get insight in T-box gene function, but also in the complex regulation of myocardial differentiation during development.
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